[96a5a0]: / output / allTrials / identified / NCT00732420_identified.json

Download this file

670 lines (670 with data), 28.8 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
{
"info": {
"nct_id": "NCT00732420",
"official_title": "A Phase I Open-label Study of the Safety, Tolerability, and Pharmacokinetics of Two Schedules of Oral Topotecan in Combination With Pazopanib in Subjects With Advanced Solid Tumors",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "Inclusion Criteria -\n\n* signed, written informed consent.\n* at least 18 years of age.\n* ECOG performance status 0 or 1.\n* Subjects must have histologically or cytologically confirmed diagnosis of advanced cancer and a solid tumor malignancy that has relapsed or is refractory to standard therapy or for which there is no established therapy.\n* able to swallow and retain oral medications.\n* females are eligible to enter and participate in this study providing adequate established contraception is being practiced.\n\nExclusion Criteria\n\n* had chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C)\n* received an investigational drug within 30 days or 5 half-lives (whichever is longer).\n* received prior treatment with pazopanib/investigational anti-angiogenic compounds.\n* presence of uncontrolled infection.\n* pregnant or lactating.\n* poorly controlled hypertension (SBP of ? 140 mmHg, or DBP of ? 90 mmHg.\n* Class III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system.-\n* arterial thrombi, myocardial infarction, admission for unstable angina, uncontrolled or symptomatic arrhythmia, cardiac angioplasty, or stenting within the last 6 months.\n* any unresolved bowel obstruction or diarrhea ? Grade 1.\n* received an allogeneic bone marrow transplant.\n* known immediate or delayed hypersensitivity reaction or idiosyncrasy to drugs chemically related to pazopanib or topotecan.\n* any serious and/or unstable pre-existing medical, psychiatric, or other conditions that could interfere with subject's safety, obtaining informed consent or compliance with the study.\n* psychological, familial, sociological, or geographical conditions that do not permit compliance with the protocol.\n* clinical history, current alcohol or illicit drug use which, in the judgment of the investigator, would interfere with the subject's ability to comply with the dosing schedule and protocol-specified evaluations."
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "* signed, written informed consent.",
"criterions": [
{
"exact_snippets": "signed, written informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
},
{
"requirement_type": "written",
"expected_value": true
}
]
}
]
},
{
"line": "* at least 18 years of age.",
"criterions": [
{
"exact_snippets": "at least 18 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* ECOG performance status 0 or 1.",
"criterions": [
{
"exact_snippets": "ECOG performance status 0 or 1",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
]
}
]
},
{
"line": "* Subjects must have histologically or cytologically confirmed diagnosis of advanced cancer and a solid tumor malignancy that has relapsed or is refractory to standard therapy or for which there is no established therapy.",
"criterions": [
{
"exact_snippets": "histologically or cytologically confirmed diagnosis of advanced cancer",
"criterion": "advanced cancer diagnosis",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
},
{
"exact_snippets": "solid tumor malignancy",
"criterion": "solid tumor malignancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "relapsed or is refractory to standard therapy",
"criterion": "response to standard therapy",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"relapsed",
"refractory"
]
}
]
},
{
"exact_snippets": "no established therapy",
"criterion": "availability of established therapy",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
}
]
},
{
"line": "* able to swallow and retain oral medications.",
"criterions": [
{
"exact_snippets": "able to swallow",
"criterion": "ability to swallow",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "retain oral medications",
"criterion": "ability to retain oral medications",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* females are eligible to enter and participate in this study providing adequate established contraception is being practiced.",
"criterions": [
{
"exact_snippets": "females are eligible",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "adequate established contraception is being practiced",
"criterion": "contraception",
"requirements": [
{
"requirement_type": "practice",
"expected_value": true
}
]
}
]
},
{
"line": "* had chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C)",
"criterions": [
{
"exact_snippets": "had chemotherapy or radiotherapy within 4 weeks",
"criterion": "chemotherapy or radiotherapy",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 4,
"unit": "weeks"
}
]
}
}
]
},
{
"exact_snippets": "6 weeks for nitrosoureas or mitomycin C",
"criterion": "nitrosoureas or mitomycin C",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 6,
"unit": "weeks"
}
]
}
}
]
}
]
},
{
"line": "* received an investigational drug within 30 days or 5 half-lives (whichever is longer).",
"criterions": [
{
"exact_snippets": "received an investigational drug within 30 days or 5 half-lives (whichever is longer)",
"criterion": "investigational drug",
"requirements": [
{
"requirement_type": "time since last dose",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 30,
"unit": "days"
}
]
}
},
{
"requirement_type": "time since last dose",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "half-lives"
}
]
}
}
]
}
]
},
{
"line": "* received prior treatment with pazopanib/investigational anti-angiogenic compounds.",
"criterions": [
{
"exact_snippets": "received prior treatment with pazopanib",
"criterion": "prior treatment with pazopanib",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "received prior treatment with ... investigational anti-angiogenic compounds",
"criterion": "prior treatment with investigational anti-angiogenic compounds",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* presence of uncontrolled infection.",
"criterions": [
{
"exact_snippets": "presence of uncontrolled infection",
"criterion": "infection",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
}
]
},
{
"line": "* pregnant or lactating.",
"criterions": [
{
"exact_snippets": "pregnant",
"criterion": "pregnancy status",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
},
{
"exact_snippets": "lactating",
"criterion": "lactation status",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
}
]
},
{
"line": "* poorly controlled hypertension (SBP of ? 140 mmHg, or DBP of ? 90 mmHg.",
"criterions": [
{
"exact_snippets": "poorly controlled hypertension (SBP of ? 140 mmHg",
"criterion": "systolic blood pressure (SBP)",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": "<=",
"value": 140,
"unit": "mmHg"
}
}
]
},
{
"exact_snippets": "poorly controlled hypertension ... DBP of ? 90 mmHg",
"criterion": "diastolic blood pressure (DBP)",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": "<=",
"value": 90,
"unit": "mmHg"
}
}
]
}
]
},
{
"line": "* Class III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system.-",
"criterions": [
{
"exact_snippets": "Class III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system",
"criterion": "heart failure",
"requirements": [
{
"requirement_type": "severity",
"expected_value": [
"Class III",
"Class IV"
]
}
]
}
]
},
{
"line": "* arterial thrombi, myocardial infarction, admission for unstable angina, uncontrolled or symptomatic arrhythmia, cardiac angioplasty, or stenting within the last 6 months.",
"criterions": [
{
"exact_snippets": "arterial thrombi",
"criterion": "arterial thrombi",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "myocardial infarction",
"criterion": "myocardial infarction",
"requirements": [
{
"requirement_type": "occurrence",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "admission for unstable angina",
"criterion": "admission for unstable angina",
"requirements": [
{
"requirement_type": "occurrence",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "uncontrolled or symptomatic arrhythmia",
"criterion": "uncontrolled or symptomatic arrhythmia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "cardiac angioplasty",
"criterion": "cardiac angioplasty",
"requirements": [
{
"requirement_type": "occurrence",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "stenting within the last 6 months",
"criterion": "stenting",
"requirements": [
{
"requirement_type": "occurrence",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* any unresolved bowel obstruction or diarrhea ? Grade 1.",
"criterions": [
{
"exact_snippets": "unresolved bowel obstruction",
"criterion": "bowel obstruction",
"requirements": [
{
"requirement_type": "resolution",
"expected_value": false
}
]
},
{
"exact_snippets": "unresolved ... diarrhea",
"criterion": "diarrhea",
"requirements": [
{
"requirement_type": "resolution",
"expected_value": false
}
]
},
{
"exact_snippets": "diarrhea ? Grade 1",
"criterion": "diarrhea",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "Grade 1"
}
]
}
]
},
{
"line": "* received an allogeneic bone marrow transplant.",
"criterions": [
{
"exact_snippets": "received an allogeneic bone marrow transplant",
"criterion": "allogeneic bone marrow transplant",
"requirements": [
{
"requirement_type": "received",
"expected_value": true
}
]
}
]
},
{
"line": "* known immediate or delayed hypersensitivity reaction or idiosyncrasy to drugs chemically related to pazopanib or topotecan.",
"criterions": [
{
"exact_snippets": "known immediate or delayed hypersensitivity reaction ... to drugs chemically related to pazopanib",
"criterion": "hypersensitivity reaction to drugs related to pazopanib",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "known immediate or delayed hypersensitivity reaction ... to drugs chemically related to ... topotecan",
"criterion": "hypersensitivity reaction to drugs related to topotecan",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* any serious and/or unstable pre-existing medical, psychiatric, or other conditions that could interfere with subject's safety, obtaining informed consent or compliance with the study.",
"criterions": [
{
"exact_snippets": "serious and/or unstable pre-existing medical ... conditions",
"criterion": "pre-existing medical conditions",
"requirements": [
{
"requirement_type": "severity/stability",
"expected_value": "serious and/or unstable"
}
]
},
{
"exact_snippets": "serious and/or unstable pre-existing ... psychiatric ... conditions",
"criterion": "pre-existing psychiatric conditions",
"requirements": [
{
"requirement_type": "severity/stability",
"expected_value": "serious and/or unstable"
}
]
},
{
"exact_snippets": "serious and/or unstable pre-existing ... other conditions",
"criterion": "pre-existing other conditions",
"requirements": [
{
"requirement_type": "severity/stability",
"expected_value": "serious and/or unstable"
}
]
}
]
},
{
"line": "* psychological, familial, sociological, or geographical conditions that do not permit compliance with the protocol.",
"criterions": [
{
"exact_snippets": "psychological ... conditions that do not permit compliance with the protocol",
"criterion": "psychological conditions",
"requirements": [
{
"requirement_type": "compliance",
"expected_value": false
}
]
},
{
"exact_snippets": "familial ... conditions that do not permit compliance with the protocol",
"criterion": "familial conditions",
"requirements": [
{
"requirement_type": "compliance",
"expected_value": false
}
]
},
{
"exact_snippets": "sociological ... conditions that do not permit compliance with the protocol",
"criterion": "sociological conditions",
"requirements": [
{
"requirement_type": "compliance",
"expected_value": false
}
]
},
{
"exact_snippets": "geographical conditions that do not permit compliance with the protocol",
"criterion": "geographical conditions",
"requirements": [
{
"requirement_type": "compliance",
"expected_value": false
}
]
}
]
},
{
"line": "* clinical history, current alcohol or illicit drug use which, in the judgment of the investigator, would interfere with the subject's ability to comply with the dosing schedule and protocol-specified evaluations.",
"criterions": [
{
"exact_snippets": "clinical history",
"criterion": "clinical history",
"requirements": [
{
"requirement_type": "interference with compliance",
"expected_value": true
}
]
},
{
"exact_snippets": "current alcohol or illicit drug use",
"criterion": "current alcohol or illicit drug use",
"requirements": [
{
"requirement_type": "interference with compliance",
"expected_value": true
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "Inclusion Criteria -",
"criterions": []
},
{
"line": "Exclusion Criteria",
"criterions": []
}
]
}